Published: 6th July 2026
Reviewed by: David Small BSc (Hons), MSc, MTOPRA (Founder and CEO)
Do You Need an EU Authorised Representative to Sell Medical Devices in Europe?
If you are a medical device or in vitro diagnostic (IVD) manufacturer based outside the European Union—whether in the UK, the United States, or the APAC region—and you are targeting the European single market, the regulatory pathway requires absolute clarity. Navigating the legal cross-currents of international compliance can be daunting, but the answer to your foundational question is definitive: Yes, you legally require an EU Authorised Representative (EC Rep).
Under Article 11 of both the EU Medical Device Regulation (MDR 2017/745) and the EU In Vitro Diagnostic Regulation (IVDR 2017/746), non-EU manufacturers cannot legally place a single device onto the EU market without formally appointing a sole EC Rep established within the Union.
However, many regulatory affairs teams and business leaders make the critical mistake of treating the EC Rep as a low-cost, hands-off “postal mailbox” service simply to tick a box for market access. Under the modern European regulatory framework, this superficial approach is a fast track to customs rejections, automated database enforcement, or catastrophic joint legal liability. To safeguard your supply chain and your business, you need a comprehensive understanding of what an EU Authorised Representative does, why the role has radically changed, and how to structure a bulletproof compliance partnership.
Need an Introduction to the EU MDR?
This article focuses on EU Authorised Representative requirements for non-EU medical device and IVD manufacturers. If you're looking for a complete overview of the Medical Device Regulation, including classification, GSPRs, Technical Documentation, UDI, EUDAMED, CE marking and post-market obligations, read our Complete Guide to the EU MDR.
Manufacturing In Vitro Diagnostic (IVD) Devices?
This article covers EU Authorised Representative requirements for both medical device and IVD manufacturers. If you're looking for a complete guide to the In Vitro Diagnostic Regulation (IVDR), including classification, performance evaluation, Technical Documentation, Notified Bodies, UDI, EUDAMED and post-market surveillance, read our Complete Guide to the EU IVDR.
What Exactly is an EU Authorised Representative (EC Rep)?
An EU Authorised Representative is a legally registered corporate entity or natural person based inside the physical territory of the European Union (or operating under specific protocols like the Northern Ireland Windsor Framework). This entity acts as the primary legal liaison and point of contact between your non-EU manufacturing facility and the 27 EU Competent Authorities, National Market Surveillance Authorities, and Notified Bodies.
Because your EC Rep acts as your legal proxy within the single market, European law dictates that their official corporate identity, designated logo, and registered physical address must be explicitly and permanently displayed on your device labelling, outer packaging, and Instructions for Use (IFU).
Under Article 11, the mandate between the manufacturer and the representative cannot be a loose verbal agreement; it must be a formal, legally binding written contract that explicitly dictates a comprehensive suite of mandatory compliance tasks.
The Core Statutory Responsibilities of an EC Rep
- Technical Documentation Verification: The representative must perform a proactive, rigorous review of your EU Declaration of Conformity and verify that your comprehensive technical files have been compiled properly in accordance with MDR or IVDR standards.
- Documentation Retention & Accessibility: The EC Rep is legally obligated to maintain an updated clone of your technical documentation, relevant certificates, and any formal design or manufacturing amendments. This data must be kept at the immediate disposal of European Competent Authorities for at least 10 years after the last device is placed on the market (and 15 years for complex implantable devices).
- EUDAMED Registrations & SRN Allocation: Your representative is responsible for validating your corporate registration inside the European Database on Medical Devices (EUDAMED). They must review and submit the data required to secure your Single Registration Number (SRN), which is your passport to commercial activity in Europe.
- Vigilance, Incident Reporting & Market Surveillance: If a healthcare professional, patient, or user inside the EU experiences a adverse event or submits a complaint regarding your device, the EC Rep acts as the local intake hub. They must immediately forward this data to you and actively collaborate with your team to coordinate Field Safety Corrective Actions (FSCAs) and draft Field Safety Notices (FSNs).
- Samples and Inspections: Upon an official request from an EU member state’s market surveillance authority, the EC Rep must facilitate the provision of device samples or grant access to the documentation required to verify product safety.
The Modern Post-Brexit Reality for UK Medical Device Manufacturers
For medical device companies headquartered in England, Scotland, or Wales, the regulatory landscape shifted permanently following the transition out of the European Union. The regulatory architecture governing Great Britain (managed by the MHRA) has fully decoupled from the European Commission’s frameworks.
A common point of confusion for British businesses involves the roles of domestic and international representatives. It is vital to understand that your UK Responsible Person (UK RP) has zero legal standing, authority, or recognition inside the European Union single market. A UK RP is strictly a domestic requirement for international companies selling into Great Britain.
If your primary manufacturing infrastructure or corporate headquarters is based in Great Britain, you are classified as an “third-country international exporter” in the eyes of European customs and member state inspectors. To clear a commercial shipment through European ports of entry (such as Rotterdam or Calais), your products must be legally backed by an active EU Authorised Representative mandate. Furthermore, under the MDR and IVDR, your designated EU Importer is legally required to physically check your packaging to ensure a valid EC Rep is clearly listed before they can clear the stock for commercial distribution.
The Northern Ireland Exception: The Windsor Framework
Under the current terms of the Windsor Framework, Northern Ireland maintains a unique regulatory status, aligning closely with EU single market rules for goods. For British manufacturers, this means that medical devices placed onto the market in Northern Ireland must comply with EU MDR or IVDR requirements. Interestingly, an EU Authorised Representative can be established inside Northern Ireland to represent a third-country manufacturer for the wider EU market, providing a unique geographic bridge for compliance operations.
The Danger of Cheap "Mailbox" Services: Joint and Several Liability
In the pre-MDR era under the old directives (MDD and IVDD), the role of the EC Rep was largely administrative. Many baseline providers operated as glorified mailboxes—charging a nominal annual fee to let manufacturers print their address on a label, while taking zero interest in the underlying technical data or clinical evidence.
The implementation of the MDR and IVDR completely obliterated this business model. To combat the distribution of non-compliant or hazardous devices, the European Commission introduced Article 11(5), which represents one of the heaviest regulatory shifts in modern corporate law:
Article 11(5) MDR/IVDR: Without prejudice to paragraph 4 of this Article, where the manufacturer is not established in a Member State and has not complied with its obligations under Article 10, the authorised representative shall be legally liable for defective devices on the same basis as, and jointly and severally with, the manufacturer.
This means that if your medical device malfunctions, causes patient harm, or faces an enforcement lawsuit inside the EU, and your company is outside European borders, your EU Authorised Representative is held fully, legally, and financially liable for the damages alongside you.
Because of this profound legal exposure, any high-quality, professional, and competent EC Rep must behave as an active, critical auditor of your business. If a third-party regulatory provider offers you an incredibly cheap, hands-off “address-only” service with no initial technical file audit, they are demonstrating a dangerous lack of understanding of European law. Alternatively, they will likely terminate your mandate instantly at the first sign of an enforcement query or Notified Body audit deficiency to protect their own corporate insurance, leaving your European sales completely stranded.
The Intersecting Role: The PRRC and the EC Rep
Another layer of topical compliance that manufacturers must navigate is the requirement for a Person Responsible for Regulatory Compliance (PRRC), as mandated by Article 15 of the MDR/IVDR. Both the non-EU manufacturer and their appointed EU Authorised Representative must have continuous and permanent access to their own respective PRRCs.
Attribute | Manufacturer’s PRRC | Authorised Representative’s PRRC |
Location | Can be outside the EU (at the manufacturing site) | Must be physically located and resident inside the European Union |
Core Duty | Ensures batch conformity, technical file up-keep, and post-market vigilance compliance | Verifies that the EC Rep’s statutory obligations under the Article 11 mandate are being executed |
Relationship | Direct employee or outsourced (for micro/small enterprises) | Independent check-and-balance verifying the manufacturer’s compliance status |
When setting up your EU infrastructure, your EC Rep will require proof that your internal PRRC is qualified (via appropriate regulatory degrees or verified professional experience) and formally designated in your quality management system (QMS).
Step-by-Step: The Onboarding Process for an EC Rep Mandate
Transitioning to an EU Authorised Representative or setting up a new mandate requires a structured approach to avoid registration gaps. The onboarding protocol should follow a highly controlled sequence:
1.Comprehensive Technical Dossier Review:
Before signing a mandate, your technical documentation, CE certificates, EU Declaration of Conformity, and device labeling layout must undergo a comprehensive gap analysis to ensure alignment with modern MDR/IVDR criteria.
2.Formal Execution of the Article 11 Mandate:
Both corporate entities draft and execute the formal written agreement, explicitly detailing the scope of devices covered by their unique Basic UDI-DIs and establishing the joint vigilance protocols.
3.EUDAMED Economic Operator Registration:
The EC Rep submits the relationship connection within the EUDAMED actor module. This application is routed to the representative’s local national Competent Authority for formal verification, leading to the generation or update of your Single Registration Number (SRN).
4.Artwork Update and Labelling Release :
The manufacturer updates all relevant device labelling, packaging artwork, and digital Instructions for Use (IFUs) to explicitly display the newly appointed EC Rep’s name and physical European address.
Critical Timeline Alert: EUDAMED Mandatory Transition and Market Enforcement
The European medical device regulatory ecosystem is entering a phase of strict enforcement regarding digital data transparency. The historical transition periods allowing for paper-based or localized tracking are drawing to an end as the European Commission accelerates the mandatory rollout of the EUDAMED database modules (specifically Actor Registration, UDI/Device Registration, and Notified Bodies/Certificates).
Moving forward, economic operators—including all international manufacturers and their appointed EU Authorised Representatives—must fully populate their device portfolios and unique device identifiers (UDI-DI) within the centralized portal.
National market surveillance authorities and customs border agents across the 27 member states are actively utilizing EUDAMED to perform spot-checks on inbound commercial shipments. If an overseas manufacturer’s portfolio is not cleanly linked to an approved, active, and verified EU Authorised Representative actor profile within the database, the shipment faces automatic border impoundment, administrative fines, and immediate removal from local hospital supply networks.
How Patient Guard Secures Your European Market Footprint
Appointing an EU Authorised Representative is not a simple, hands-off administrative transaction; it is a foundational, long-term operational partnership that dictates the security of your international revenue streams.
At Patient Guard, we function as a professional services business rather than a generic administrative registry. We provide global medical device and IVD manufacturers with a seamless, highly integrated bridge into both the United Kingdom and European single markets through our advanced regulatory compliance infrastructure and seasoned in-house auditing teams.
When you partner with Patient Guard for your EU Authorised Representative representation, you secure:
- Proactive Pre-Market Technical Verification: Our senior regulatory specialists perform an exhaustive, independent technical audit of your technical files, clinical evaluations, and label layouts. This drastically reduces the risk of sudden Notified Body pushback or costly custom border holds before your legal mandate goes live.
- End-to-End EUDAMED Database Management: We assume full responsibility for your EUDAMED actor profile setup, relationship mapping, and ongoing UDI data population, securing your Single Registration Number (SRN) with absolute clarity and zero hidden administrative overheads.
- Active Regulatory Intelligence & Surveillance Support: We actively monitor the constantly evolving landscape of EU member state competent authority mandates, ensuring that your corporate Quality Management System (QMS) and post-market surveillance (PMS) strategies remain completely updated in real-time.
- Dual-Market Harmonization: For businesses targeting both Great Britain and continental Europe, our infrastructure allows you to centralize your UK Responsible Person (UK RP) duties and your European EC Rep obligations under a single, highly coordinated professional consultancy team, eliminating fractured communication and redundant compliance spend.
Ready to Secure Your European Launch?
Do not let escalating regulatory bottlenecks, evolving database deadlines, or sub-standard technical representation disrupt your global supply chain. Speak with our specialized medical device and IVD regulatory team today to establish a secure, fully compliant EU Authorised Representative framework for your product portfolio.
Frequently Asked Questions About EU Authorised Representatives
Do all non-EU medical device manufacturers need an EU Authorised Representative?
Yes. Under Article 11 of EU MDR 2017/745 and IVDR 2017/746, manufacturers established outside the European Union must appoint an EU Authorised Representative before placing medical devices or IVDs on the EU market. Without an appointed EC Rep, products cannot legally be marketed within the EU.
What is the difference between an EU Authorised Representative and a UK Responsible Person?
An EU Authorised Representative represents non-EU manufacturers within the European Union and fulfils obligations under the EU MDR and IVDR. A UK Responsible Person represents non-UK manufacturers placing devices on the Great Britain market under UK medical device regulations. One appointment does not replace the other if you sell in both markets.
Can I change my EU Authorised Representative?
Yes. Manufacturers can transfer to a new EU Authorised Representative at any time, provided the existing mandate is formally terminated, a new Article 11 mandate is signed, EUDAMED records are updated where applicable, and product labelling is amended to display the new representative's details.
Is an EU Authorised Representative legally liable for my medical devices?
Yes. Under Article 11(5) of the MDR and IVDR, an EU Authorised Representative may share joint and several liability with the manufacturer if the manufacturer fails to meet its regulatory obligations. This is why reputable EC Reps conduct technical documentation reviews and ongoing compliance monitoring rather than simply providing a postal address.
What information must appear on my product labels?
Medical devices sold in the European Union must display the name and address of the appointed EU Authorised Representative on the device label, packaging and, where applicable, the Instructions for Use (IFU). The information must remain accurate throughout the product's lifecycle.
Does my EU Authorised Representative register my company in EUDAMED?
Your EU Authorised Representative plays a key role in supporting EUDAMED registration, including Economic Operator registration and obtaining your Single Registration Number (SRN). They also help ensure your regulatory information remains accurate as EUDAMED modules become fully mandatory.
How do I choose the right EU Authorised Representative?
Choose an EU Authorised Representative with proven expertise in EU MDR and IVDR, experienced regulatory specialists, comprehensive technical documentation reviews, EUDAMED support, post-market surveillance expertise, and robust professional indemnity insurance. Avoid providers offering low-cost "mailbox" services that do not actively assess your compliance.
Patient Guards Recent Posts
EU Authorised Representative Services for Medical Device & IVD Manufacturers
Selling medical devices or IVDs in Europe? If your company is based outside the EU, appointing an EU Authorised Representative (EC Rep) is a legal requirement under EU MDR 2017/745 and IVDR 2017/746. Patient Guard provides expert EU Authorised Representative services, EUDAMED support, regulatory guidance, and ongoing compliance management to help manufacturers access and maintain the European market with confidence.
Predetermined Change Control Plans (PCCPs): The Future of Agile Compliance for Medical Device Software
Learn how PCCPs help medical device software manufacturers manage updates, support AI systems, and enable agile compliance under evolving MDR and UKCA frameworks.
The AI Act Omnibus Explained: What the 2026 EU Rules Mean for Medical Device and IVD Manufacturers
Discover how the EU AI Act Omnibus affects AI medical devices and IVD manufacturers. Learn about the No Duplication principle, transparency rules, key 2026 and 2028 deadlines, and how MDR and IVDR compliance are converging with AI regulation.
Need Training?
Do you need training on Quality Management Systems or EU MDR/ EU IVDR? then check out our training courses.
